D. Morales

First name
Middle name
Last name
Voss, E. A., Shoaibi, A., Lai, Y. H., Blacketer, C., Alshammari, T., Makadia, R., et al. (2023). Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. Eclinicalmedicine, 58, 101932. http://doi.org/10.1016/j.eclinm.2023.101932
Livingstone, S., Morales, D. R., Fleuriot, J., Donnan, P. T., & Guthrie, B. (2023). External validation of the QLifetime cardiovascular risk prediction tool: population cohort study. Bmc Cardiovasc Disord, 23, 194. http://doi.org/10.1186/s12872-023-03209-8
Livingstone, S. J., Morales, D. R., McMinn, M., Eke, C., Donnan, P., & Guthrie, B. (2022). Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population. Bmj Med, 1, e000316. http://doi.org/10.1136/bmjmed-2022-000316
Livingstone, S. J., Guthrie, B., McMinn, M., Eke, C., Donnan, P. T., & Morales, D. R. (2023). Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study. Lancet Healthy Longev, 4, e43-e53. http://doi.org/10.1016/s2666-7568(22)00290-2
McGettigan, P., Morales, D. R., Moreno-Martos, D., & Matin, N. (2022). Changing co-morbidity and increasing deprivation among people living with HIV: UK population-based cross-sectional study. Hiv Med. http://doi.org/10.1111/hiv.13389
Livingstone, S. J., Guthrie, B., Donnan, P. T., Thompson, A., & Morales, D. R. (2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. Bmc Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6
Burn, E., Li, X., Kostka, K., Stewart, H. M., Reich, C., Seager, S., et al. (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495-510. http://doi.org/10.1002/pds.5419
Morales, D. R., Moreno-Martos, D., Matin, N., & McGettigan, P. (2022). Health conditions in adults with HIV compared with the general population: A population-based cross-sectional analysis. Eclinicalmedicine, 47, 101392. http://doi.org/10.1016/j.eclinm.2022.101392
Morales, D. R., Donnan, P. T., Daly, F., Staa, T. V., & Sullivan, F. M. (2013). Impact of clinical trial findings on Bell\textquoterights palsy management in general practice in the UK 2001-2012: interrupted time series regression analysis. BMJ Open. http://doi.org/10.1136/bmjopen-2013-003121
Morales, D. R., Dreischulte, T., Lipworth, B. J., Donnan, P. T., Jackson, C., & Guthrie, B. (2016). Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13006